Nanomolar Protein-Protein Interaction Monitoring with a Label-Free Protein-Probe Technique.


Journal

Analytical chemistry
ISSN: 1520-6882
Titre abrégé: Anal Chem
Pays: United States
ID NLM: 0370536

Informations de publication

Date de publication:
15 12 2020
Historique:
pubmed: 26 11 2020
medline: 18 2 2021
entrez: 25 11 2020
Statut: ppublish

Résumé

Protein-protein interactions (PPIs) are an essential part of correct cellular functionality, making them increasingly interesting drug targets. While Förster resonance energy transfer-based methods have traditionally been widely used for PPI studies, label-free techniques have recently drawn significant attention. These methods are ideal for studying PPIs, most importantly as there is no need for labeling of either interaction partner, reducing potential interferences and overall costs. Already, several different label-free methods are available, such as differential scanning calorimetry and surface plasmon resonance, but these biophysical methods suffer from low to medium throughput, which reduces suitability for high-throughput screening (HTS) of PPI inhibitors. Differential scanning fluorimetry, utilizing external fluorescent probes, is an HTS compatible technique, but high protein concentration is needed for experiments. To improve the current concepts, we have developed a method based on time-resolved luminescence, enabling PPI monitoring even at low nanomolar protein concentrations. This method, called the protein probe technique, is based on a peptide conjugated with Eu

Identifiants

pubmed: 33237744
doi: 10.1021/acs.analchem.0c02823
pmc: PMC7745204
doi:

Substances chimiques

Chelating Agents 0
EIF4A1 protein, human 0
KRAS protein, human 0
Peptides 0
Europium 444W947O8O
Eukaryotic Initiation Factor-4A EC 2.7.7.-
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15781-15788

Subventions

Organisme : Medical Research Council
ID : MC_UP_A600_1024
Pays : United Kingdom

Références

Anal Chem. 2017 Apr 18;89(8):4508-4516
pubmed: 28318223
Anal Biochem. 1987 Dec;167(2):228-34
pubmed: 3442318
Scand J Clin Lab Invest. 1989 Jun;49(4):389-93
pubmed: 2662385
Nature. 2007 Dec 13;450(7172):1001-9
pubmed: 18075579
J Vis Exp. 2017 Mar 4;(121):
pubmed: 28287565
Adv Protein Chem Struct Biol. 2018;110:1-30
pubmed: 29412994
Biochim Biophys Acta. 2007 Mar;1774(3):403-11
pubmed: 17321809
Arch Biochem Biophys. 2013 Mar;531(1-2):100-9
pubmed: 23022410
Cell Chem Biol. 2017 Aug 17;24(8):1005-1016.e3
pubmed: 28781124
Curr Top Med Chem. 2018;18(8):674-699
pubmed: 29848279
Nat Rev Mol Cell Biol. 2010 Feb;11(2):113-27
pubmed: 20094052
J Mol Biol. 2011 Sep 30;412(4):674-87
pubmed: 21840318
Anal Chem. 2020 Apr 7;92(7):4971-4979
pubmed: 32106676
Adv Protein Chem Struct Biol. 2018;110:31-63
pubmed: 29412999
Cell. 2018 Jan 11;172(1-2):358-372.e23
pubmed: 29307493
Curr Opin Chem Biol. 2018 Jun;44:75-86
pubmed: 29908451
Anal Bioanal Chem. 2014 Jul;406(17):4147-56
pubmed: 24760397
Genome Biol. 2019 Dec 2;20(1):262
pubmed: 31791371
J Mol Recognit. 1999 Jan-Feb;12(1):3-18
pubmed: 10398392
Curr Opin Struct Biol. 2017 Oct;46:16-23
pubmed: 29800904
Curr Opin Chem Biol. 2004 Feb;8(1):33-41
pubmed: 15036154
Nat Protoc. 2007;2(9):2212-21
pubmed: 17853878
Pharm Res. 2008 Jul;25(7):1487-99
pubmed: 18172579
Curr Protoc Protein Sci. 2015 Feb 02;79:28.9.1-28.9.14
pubmed: 25640896
Methods Mol Biol. 2009;544:201-29
pubmed: 19488702
Cold Spring Harb Perspect Biol. 2012 Oct 01;4(10):
pubmed: 22815232
J Am Chem Soc. 2009 Mar 25;131(11):3794-5
pubmed: 19292479
Biotechnol Prog. 2017 May;33(3):677-686
pubmed: 28371560
Proteomics. 2007 Aug;7(16):2833-42
pubmed: 17640003
J Pharm Bioallied Sci. 2011 Jan;3(1):39-59
pubmed: 21430954
Anal Chem. 2020 Mar 3;92(5):3512-3516
pubmed: 32013400
Cell. 2009 Feb 6;136(3):447-60
pubmed: 19203580
Biol Cell. 2009 Jun;101(6):309-17
pubmed: 19356152
Mol Cell Biol. 2003 Jan;23(1):26-37
pubmed: 12482958
Cell Rep. 2016 Jun 14;15(11):2340-7
pubmed: 27239032
Chembiochem. 2013 Feb 11;14(3):332-42
pubmed: 23344974
J Biol Chem. 2001 Aug 17;276(33):30914-22
pubmed: 11418588
Nat Biotechnol. 2004 May;22(5):575-82
pubmed: 15097997
Nat Commun. 2017 Jul 14;8:16111
pubmed: 28706291
EMBO J. 2009 Feb 4;28(3):274-85
pubmed: 19153607
J Biol Chem. 2011 May 13;286(19):17270-80
pubmed: 21454508
J Biomol Screen. 2001 Dec;6(6):429-40
pubmed: 11788061
Anal Bioanal Chem. 2003 Nov;377(5):834-42
pubmed: 12904946
Science. 1989 Jan 6;243(4887):85-8
pubmed: 2911722
Proteomics. 2012 May;12(10):1478-98
pubmed: 22711592
Anal Biochem. 2004 Sep 1;332(1):153-9
pubmed: 15301960

Auteurs

Salla Valtonen (S)

Department of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.

Emmiliisa Vuorinen (E)

Department of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.

Taru Kariniemi (T)

Department of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.

Ville Eskonen (V)

Department of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.

John Le Quesne (J)

University of Cambridge, MRC Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 7HB, U.K.

Martin Bushell (M)

Cancer Research U.K. Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.
Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1QH, U.K.

Harri Härmä (H)

Department of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.

Kari Kopra (K)

Department of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH